Rakesh Karmacharya, MD, PhD
Medical Director, McLean OnTrackTM
- Associate Professor of Psychiatry
Rakesh Karmacharya, MD, PhD, is working at the intersection of chemical biology and stem cell biology to investigate the cellular-molecular underpinnings of schizophrenia and bipolar disorder, using patient-specific stem cells to generate human neuronal cultures. His current research aims to discover new pathways relevant to disease biology and develop small molecules that can be translated into novel therapies through the application of chemical biology approaches.
Dr. Karmacharya is medical director of McLean OnTrackTM, director of Stem Cell Research at the MGH Center for Experimental Drugs & Diagnostics and an associate professor of psychiatry at Harvard Medical School. He is a faculty member in the Harvard Chemical Biology Program and the Harvard Program in Neuroscience and is also an associate member of the Chemical Biology Program at the Broad Institute of Harvard and MIT, and an affiliate faculty member at the Harvard Stem Cell Institute.
Education & Training
- 1993 AB in Biochemical Sciences, Harvard University
- 1994 MS in Molecular Biophysics and Biochemistry, Yale University
- 2002 MD, PhD in Biophysics, Albert Einstein College of Medicine
- 2009 MMSc, Harvard Medical School
- 2002-2003 Residency in Internal Medicine, Massachusetts General Hospital
- 2003-2006 Residency in Psychiatry, Massachusetts General Hospital/McLean Hospital
- 2005-2006 Chief Resident, Schizophrenia and Bipolar Disorder Program, McLean Hospital
- 2006-2011 Post-Doctoral Fellowship in Chemical Biology, Broad Institute of Harvard and MIT
- 2004 Medical License, Board of Registration in Medicine, Commonwealth of Massachusetts
- 2007, 2017 Psychiatry, American Board of Psychiatry and Neurology